<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

Rising Healthcare Costs: What Charles River Laboratories International Employees Need to Know About Managing Financial Strain in Retirement

image-table

As Patrick Ray, a representative of The Retirement Group, a division of Wealth Enhancement Group, points out, 'It is crucial for all employees, especially those in the Charles River Laboratories International sector, to proactively plan their finances to avoid the unexpected costs of health crises.

According to Michael Corgiat of The Retirement Group, a division of Wealth Enhancement Group, 'It is important for Charles River Laboratories International employees to understand the bigger economic implications of health issues as reported in this article to have robust financial plans to manage the risks of healthcare adverse events.

In this article, we will discuss:

1. The Economic Impact of Cancer:  Examining the direct and indirect financial challenges faced by patients, including increased medical costs and loss of income.

2. Personal Stories of Financial Struggle:  Highlighting individual cases, such as Gwendolyn Jackson, to illustrate the broader financial implications of a cancer diagnosis.

3. Solutions and Support Systems:  Exploring available resources and potential strategies to alleviate the financial burdens on patients and their families.

When one is diagnosed with cancer, it is not only a life-threatening disease that affects the patient’s health but also their finances.  Many patients are faced with the financial challenges of higher out-of-pocket costs, reduced income and higher cost of drugs. This article looks at the huge financial impact that cancer has on Americans and Charles River Laboratories International employees, using cases, numbers and the overall trend of this new epidemic.

The Story of Gwendolyn Jackson and the Personal Toll of Cancer Gwendolyn Jackson had no problems paying her bills before being diagnosed with cervical cancer. She owned her house, had insurance and had a job. But when she was 53 years old, her life changed drastically when she was told she had cervical cancer.  Jackson lost her work as a housing coordinator due to the physical toll of chemotherapy and a subsequent stroke, and she is already facing tens of thousands of dollars in medical debt.

Her vehicle was repossessed, and she received an eviction notice.  Jackson recalls, 'I woke up one morning, and I was a top case manager. Then I was losing everything.' Increasing Prices and Economic Difficulties Cancer is becoming an increasingly expensive disease in the United States due to the rising prices of drugs and medical care.  Iqvia’s Institute for Human Data Science predicts that 55% of cancer medications launched between 2019 and 2023 will cost more than $200,000 a year.

Those of working age, like those at Charles River Laboratories International, have several difficulties and are more likely to report financial hardship after diagnosis.  Sixty percent of cancer survivors of working age have money problems, according to the study. Many struggle to pay for medical care, and this often results in debt accumulation — payday loans, credit card debt, and so on. About 40 percent of medical GoFundMe campaigns are for cancer.  Radiation oncologist Dr. Reshma Jagsi of Emory University School of Medicine and the Winship Cancer Institute says, “We do not want to believe that people with cancer in this country have to cut back on medications, doctor visits, lose their home, or cut back on food.” The Financial Toxicity Concept Financial toxicity is the term used to describe the financial burden of cancer and its treatment.  It is not just the cost of treatment and the expensive drugs but there are many other costs as well.

Patients who receive chemotherapy and other treatments may not have enough energy to work, thus, losing their employer-sponsored health insurance and income.  The financial consequences may last for many years. It is always a shock. As Charles River Laboratories International Employees planning for these unexpected expenses is crucial. Dr. Fumiko Chino, a radiation oncologist at Memorial Sloan Kettering Cancer Center adds, “It can cause this wealth shock that can ripple on.” Her husband died of cancer more than 10 years ago and she still gets phone calls from debt collectors about his debts.  She faced the financial burden personally.

The Growing Price of Anticancer Drugs The chief problem facing Charles River Laboratories International employees is the rising cost of healthcare and cancer medications. These costs are either rising at the rate of inflation or have very high initial prices.  The prices of common cancer medications can be as high as six digits. For example, Medicare beneficiaries will have to pay $5,247 out-of-pocket for the leukemia therapy Imbruvica in 2022, which is more than $213,000 per year. Tagrisso lung cancer medication is approximately $208,000 per year.

Some employer-based plans have patients pay a portion of the drug costs, shifting the burden of rising healthcare costs to patients. Cancer patients of working age with private insurance had out-of-pocket expenses rise 15% between 2009 and 2016. Many patients have to pay for parking, hotel, child care, and transportation, among other costs.  The Broader Effect on Earnings Besides the cost of treatment, cancer has a major negative impact on the financial well-being of the affected individuals. It is still a serious matter that makes many have to leave their workplaces or even quit their jobs altogether.  Chemotherapy patients are four times more likely to quit than patients who do not receive the treatment within the first four years.

Featured Video

Articles you may find interesting:

Loading...

This burden usually affects families as a whole since relatives may have to take care of the patient or financially support the family.  The hardship faced by Erica Olenski is illustrative. Olenski’s young son August was diagnosed with brain cancer in 2019. She cut back drastically on her working hours, spending time traveling back and forth between McKinney, Texas, and Dallas for August’s treatments, which entailed weekly hospital stays.

The family’s income was lowered even though Medicaid paid for the medical expenses. “It was the transport, gas, tolls, food at the hospital because you can’t buy groceries like you would at home,” says Olenski. “There’s a pragmatic reality of living that lifestyle that carries an enormous cost.” Financial Repercussions and Insolvency Financial strain may have serious implications for Charles River Laboratories International employees and may include bankruptcy.  Olenski had to liquidate most of her 401(k) to pay off the debts. She later got divorced and lost $20,000 during the divorce process. In 2023, August’s illness returned, and she had to use her credit cards to pay for things like car and mortgage.  She finally filed for bankruptcy, and was over $100,000 in debt.

Cancer’s Wider Financial Effects Dr. Scott Ramsey, the director of the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Center, and his team found that cancer patients have more credit card late payments, mortgage defaults, and other financial issues than non-cancer patients.  According to Ramsey, patients who incur more out-of-pocket expenses are more likely to delay starting their prescriptions or stop taking them altogether.

According to his research, cancer patients who file for bankruptcy have an 80 percent higher chance of dying than those who do not.  “It was actually kind of bad for the survival,” he said. Gwendolyn Jackson’s Persistent Battle When Jackson’s father was diagnosed with lung cancer 10 years ago, she saw for herself how cancer affects people’s finances. Inspired by families who had to sell their jewelry and savings to pay for treatment, she started a charity organization to help cancer patients and their families.  She is currently in a comparable situation. Her diagnosis has greatly impacted Jackson’s life. She has gone from a social person who used to jog daily to a person with a very busy schedule of doctor’s appointments.

Her 83-year-old mother had to pay $800 a month for her health insurance until it became unaffordable after she quit her job in 2022.  Jackson then chose a less expensive insurance plan, but the costs for tests, chemotherapy, and physical therapy kept on rising. While waiting for long-term disability, she used her credit cards and received money from friends and relatives. She moved in with her daughter and shared a room with her grandson after losing her house and car.  “It broke me,” Jackson claims. Looking for Guidance and Assistance Despite substantial holes in the safety net, campaigners and doctors are looking for patchwork solutions to the increasing problems.

More cancer facilities are now able to help patients who have financial problems and other needs like food and transportation.  The problem is that there is not much funding and not many people are aware of these options. Only a few patients who turn to crowdfunding platforms like GoFundMe can raise the needed amount through the platform. Cancer Care Kansas had not considered Jackson for aid because she earned too much money.

She was able to avoid using cash from her nonprofit because she had to. She could not manage the demands and her efforts to work remotely were in vain. Jackson is now on disability, so she helps pay for groceries, gas, utilities, and prescription drugs.  She has just been informed that she would be eligible for Medicare in a few months’ time, but this will leave her with around $38,000 of medical debt that she has no way of paying after monthly expenses are covered.

Jackson’s cancer has not responded to chemotherapy, so she is still undergoing treatment through a clinical trial. Despite the fact that she has less than 18 months to live, debt collectors are still after her for the medical bills. “They’ll give you calls and letters,” she continues.  “But I can’t pay for what I don’t have.” In Summary Cancer impacts the lives of American households in a real and significant way. The costs of prescription drugs, the out-of-pocket costs, and the lower incomes are a financial burden that many patients and their families cannot bear.

The stories of people like Gwendolyn Jackson and Erica Olenski show that there is a need for better financial support and ways to help people cope with the economic impact of cancer. This is becoming more important as the cost of cancer treatment rises, so patients can focus on their health without worrying about the financial impact.  It is important for Charles River Laboratories International employees to always be prepared for any unexpected medical expenses.

Medicare enrollees paid $5,460 on average out-of-pocket for healthcare in 2021, according to a recent Kaiser Family Foundation report released in May 2023. Healthcare costs were substantially higher for people with serious diseases like cancer.  Such costs can strip retirement funds quickly, and it is crucial to understand and prepare for healthcare expenses in later years. Older retirees may struggle with financial issues that threaten their financial well-being and quality of life as healthcare costs rise (KFF, 2023).  Disclosure: This information is not intended as recommendation. The opinions are subject to change at any time and no forecasts can be guaranteed.  Investing involves risk, including possible loss of principal.

Sources:

1. 'Financial Hardship.' American Cancer Society. www.cancer.org. The following is a reference from the American Cancer Society on financial difficulties encountered by cancer patients and the need for support and resources.

2. 'The Economic Burden of Cancer.' The Cancer Atlas. canceratlas.cancer.org. This article presents the costs of cancer in the US and EU and shows that the costs are high.

3. 'The Financial Impact of Cancer: How to Manage the Costs.' Cancer Survivors Network.  csn.cancer.org. This narrative focuses on financial assistance and community resources for cancer patients with a focus on long-term financial planning.

4. 'CRFT Brings Distress, Bankruptcy, and Mortality.' Family Reach. www.familyreach.org. This article explores the financial devastation that cancer can cause and the consequences of heightened chances of bankruptcy and death.

5. 'Legal & Financial Impacts of Cancer.' MD Anderson Cancer Center. www.mdanderson.org. This source provides information on the legal and financial challenges of cancer patients, including information on managing health insurance and healthcare costs.

What type of retirement savings plan does Charles River Laboratories International offer?

Charles River Laboratories International offers a 401(k) retirement savings plan to its employees.

Does Charles River Laboratories International match employee contributions to the 401(k) plan?

Yes, Charles River Laboratories International provides a matching contribution to employee 401(k) contributions, subject to certain limits.

What is the eligibility requirement to participate in the 401(k) plan at Charles River Laboratories International?

Employees of Charles River Laboratories International are generally eligible to participate in the 401(k) plan after completing a specified period of service.

How can employees of Charles River Laboratories International enroll in the 401(k) plan?

Employees can enroll in the 401(k) plan through the company’s benefits portal or by contacting the HR department at Charles River Laboratories International.

What investment options are available in the 401(k) plan at Charles River Laboratories International?

Charles River Laboratories International offers a variety of investment options in its 401(k) plan, including mutual funds, target-date funds, and other investment vehicles.

Can employees of Charles River Laboratories International take loans against their 401(k) savings?

Yes, Charles River Laboratories International allows employees to take loans against their 401(k) savings, subject to the plan's rules and regulations.

What is the vesting schedule for employer contributions in the 401(k) plan at Charles River Laboratories International?

The vesting schedule for employer contributions at Charles River Laboratories International may vary, but typically follows a graded vesting schedule over several years.

How often can employees of Charles River Laboratories International change their 401(k) contributions?

Employees can change their 401(k) contribution amounts at any time, subject to the plan's guidelines set by Charles River Laboratories International.

Are there any fees associated with the 401(k) plan at Charles River Laboratories International?

Yes, there may be administrative fees associated with the 401(k) plan at Charles River Laboratories International, which are disclosed in the plan documents.

What resources does Charles River Laboratories International provide to help employees manage their 401(k) investments?

Charles River Laboratories International provides educational resources, access to financial advisors, and online tools to help employees manage their 401(k) investments.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Update: In 2024, Charles River Laboratories International has announced a significant overhaul of its 401(k) plan, which includes increasing the company match percentage and introducing a new vesting schedule. This change is aimed at improving employee retention and competitive positioning. The update is crucial in the current economic environment where employees are seeking better retirement benefits amid economic uncertainty.
Restructuring Layoffs: Charles River Laboratories announced a workforce reduction in early 2024. The company is consolidating its facilities and focusing on higher-margin services, resulting in layoffs primarily affecting administrative and support roles. This restructuring is part of their broader strategy to streamline operations and reduce costs amidst economic uncertainty.
Charles River Laboratories International Stock Options and RSUs 2022 Stock Options: Charles River Laboratories International granted stock options primarily to executives and senior management. These options typically had a vesting period of 4 years with annual vesting in 25% increments. RSUs: RSUs were awarded to a broader employee base, including senior executives and key employees. These units generally vested over a period of 3 years with a performance component tied to company goals. Availability: Stock options and RSUs were part of the company's broader compensation package to attract and retain top talent, with specific allocations based on role and performance. 2023 Stock Options: Charles River Laboratories International continued to offer stock options, mainly to higher-level executives and employees in strategic roles. The options typically had a 4-year vesting schedule with performance criteria. RSUs: In 2023, Charles River Laboratories International expanded its RSU program to include mid-level management. The vesting schedule remained similar, with a 3-year timeline and performance metrics. Availability: Both stock options and RSUs were used to incentivize employees and align their interests with company performance, with allocation levels varying by position and individual performance. 2024 Stock Options: For 2024, Charles River Laboratories International maintained its stock option program, focusing on key positions and high performers. The vesting schedule continued to be spread over 4 years. RSUs: The RSU program for 2024 included adjustments to address market conditions and employee retention. The vesting period stayed at 3 years, with an increased emphasis on performance-based criteria. Availability: The stock options and RSUs were integral to the company’s compensation strategy, aimed at rewarding contributions and aligning employee interests with the company’s long-term goals.
New call-to-action

Additional Articles

Check Out Articles for Charles River Laboratories International employees

Loading...

For more information you can reach the plan administrator for Charles River Laboratories International at 251 Ballardvale St. Wilmington, MA 1887; or by calling them at 1-781-222-6000.

https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia https://www.marketwatch.com/ http://www.thelayoff.com/ http://www.sec.gov/ http://www.fidelity.com/ http://www.morningstar.com/ http://www.bloomberg.com/ https://www.thelayoff.com/ https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Charles River Laboratories International employees